Skip to Content
  • 2.2
    Impact Factor
  • 2.2
    CiteScore
  • 25 days
    Submission to First Decision
  • 5 days
    Acceptance to Publication

Neuroglia

Neuroglia is an international, peer-reviewed, open access journal on Neuroscience published quarterly online by MDPI.

Get Alerted

Add your email address to receive forthcoming issues of this journal.

All Articles (188)

  • Review
  • Open Access

Gliomas remain refractory to contemporary neurosurgical and adjuvant therapies due to diffuse infiltration, immune evasion, and rapid development of therapeutic resistance. Extracellular vesicles (EVs), lipid-encapsulated substrates of various sizes that carry nucleic acid or proteins, are now recognized as central regulators of tumor–immune crosstalk and a potential unifying mechanism linking microenvironmental reprogramming with disease progression. Glioma-derived EVs function as active signaling platforms that remodel the tumor microenvironment. EV cargo—including PD-L1, TGF-β, and regulatory microRNAs—suppresses cytotoxic T-cell function, promotes M2 macrophage polarization, and impairs dendritic cell antigen presentation, collectively reinforcing an immunosuppressive niche. Additionally, EV-mediated transfer of resistance-associated cargo contributes to chemoresistance and radioresistance, representing key paracrine mechanisms of treatment failure. EV-associated nucleic acids specifically have enabled detection of alterations such as EGFRvIII, IDH1 mutations, and MGMT promoter methylation in early clinical studies. These findings support EV-based liquid biopsy as a promising approach for minimally invasive molecular characterization and disease monitoring. However, most mechanistic and therapeutic evidence remains preclinical, while clinical studies are limited by small cohorts, heterogeneous EV isolation and characterization methods, and a lack of prospective validation. Ultimately, EVs represent a biologically important interface between glioma biology and the immune microenvironment, with emerging applications in disease monitoring and therapeutic development. Prospective validation and technical standardization remain essential to enable clinical translation.

Neuroglia

13 November 2026

Extracellular vesicles as a unifying platform in glioma biology.
  • Article
  • Open Access

Background/Objectives: Oligodendrocyte maturation and function are stimulated by insulin and insulin-like growth factor (IGF) signaling through Akt-mTOR and Notch. Dysregulation of these pathways is associated with impaired white matter development; yet, treatment with insulin-sensitizing agents failed to restore oligodendrocyte function, leading to the hypothesis that additional signaling pathways are needed for oligodendrocyte function. Methods: Experiments were conducted using human MO3.13 cells to investigate the role of epidermal growth factor receptor (EGFR) expression and signaling as potential mediators of immature oligodendroglia function and mechanistic interactions with insulin/IGF and Notch pathways. Methodologies included cell function, cytomorphology, immunoassays, and RNA hybridization assays. Results: Although EGF, TGF-α, and TGF-β increased the relative levels of EGFR tyrosine phosphorylation (pY-EGFR), MTT activity, and proliferating cell nuclear antigen, EGF and TGF-β increased pY-Erk MAPK and GALC expression and reduced activated Caspase 3, while EGF selectively increased CNPase, MAG, MOG, and MBP. EGF and TGF-α stimulated IGF2, INSULINR, IGF1R, IGF2R, IRS1, and IRS2 mRNA transcripts, while TGF-α and TGF-β increased expression of NOTCH1, JAGGED1, HES1, HEY1, and HIF1A Notch network genes. Conclusions: EGF, TGF-α, and TGF-β differentially modulated the effects of EGFR stimulation on oligodendroglia-related functions, including protein expression. The findings highlight the potential importance of EGFR pathway signaling and its interactions with insulin/IGF and Notch pathways for regulating oligodendrocyte functions during development.

Neuroglia

5 November 2026

Trophic factor effects on MO3.13 culture viability, cellular abundance, MTT activity, proliferating cell nuclear antigen (PCNA), Ki-67, and activated Caspase 3. MO3.13 micro-cultures (96-well) were stimulated with 0.5% FBS (Control), 10 nM insulin, or 10 ng/mL IGF-1, TGF-α, TGF-β, or EGF (n = 12/treatment) for 24 h. The cells were assayed in situ for (A) crystal violet staining, (B) H33342 fluorescence, (C) MTT activity, (D) MTT normalized to H33342 (MTT/H33342), and (E) PCNA, (F) Ki-67, (G) activated Caspase-3, and (H) RPLP0 immunoreactivity. Box-and-whisker plots display the horizontal mean values, 95% confidence interval limits (upper and lower edges of the boxes), and range (whiskers). Inter-group comparisons were made by one-way ANOVA (Table S5) with post hoc Tukey tests. Significant differences (p ≤ 0.05) relative to the control are shown within the panels.
  • Review
  • Open Access

Vascular contributions to cognitive impairment and dementia (VCID) have emerged as critical determinants of age-related cognitive decline, yet they remain insufficiently recognized in both clinical practice and research. This comprehensive review synthesizes current understanding of the pathophysiological mechanisms linking chronic cerebral hypoperfusion (CCH) to vascular dementia (VaD) and related cognitive disorders. We examine the epidemiology, classification, and clinical heterogeneity of vascular cognitive impairment, emphasizing the convergence of cerebrovascular pathology on common pathogenic cascades including neurovascular unit dysfunction, white matter degeneration, neuroinflammation, and blood–brain barrier disruption. Particular attention is directed toward the selective vulnerability of specific brain regions to chronic hypoperfusion, the molecular mechanisms driving persistent neuroinflammation, and the role of peripheral immune cell infiltration in disease progression. We critically evaluate experimental models of CCH and discuss emerging therapeutic strategies including ischemic preconditioning and remote ischemic conditioning. Finally, we highlight the importance of sex differences in disease susceptibility, progression, and therapeutic response, emphasizing the need for sex-specific approaches in future research and clinical management.

Neuroglia

2 November 2026

This schematic illustrates the heterogeneous nature of vascular dementia (VaD) through four complementary classification systems. The anatomical approach distinguishes cortical VaD from subcortical VaD, primarily associated with cerebral small vessel disease (CSVD). The etiological classification categorizes VaD based on underlying pathology, including hypoperfusion, large-vessel occlusion, small-vessel disease, hemorrhagic lesions, hereditary arteriopathies (such as CADASIL), and mixed etiologies. Clinically, VaD presents as multi-infarct dementia (MID) with stepwise decline, strategic infarct dementia resulting from single critical lesions affecting regions such as the thalamus, hippocampus, basal ganglia, or angular gyrus, and Binswanger disease characterized by diffuse subcortical leukoencephalopathy. Finally, modern conceptual frameworks including vascular cognitive impairment (VCI) and vascular contributions to cognitive impairment and dementia (VCID) encompass the full spectrum of cerebrovascular-related cognitive dysfunction, from mild deficits to severe dementia, acknowledging the frequent coexistence of vascular and neurodegenerative pathology in aging populations.
  • Review
  • Open Access

Experience-Dependent Neuroglial Plasticity in Autism Spectrum Disorder

  • Francisco S. B. Mota,
  • Messias V. Oliveira and
  • Vinicius J. S. Osterne
  • + 7 authors

Experience-dependent plasticity involves coordinated changes in neuronal and glial function, but the glial contribution to circuit adaptation in autism spectrum disorder (ASD) remains incompletely understood. Astrocytes monitor synaptic activity and metabolic demand, microglia participate in activity-dependent synaptic remodeling, and oligodendrocyte-lineage cells adjust differentiation and myelination in response to neuronal firing and learning. Human induced pluripotent stem cell models, xenotransplantation studies, postmortem single-cell datasets and genetic models implicate these cells in ASD-associated circuit dysfunction, with causal contributions having been demonstrated for defined phenotypes in experimental systems. In this narrative review, we integrate this evidence with studies of sensory stimulation and deprivation, motor learning and social experience to examine how glia may link repeated activity with durable circuit adaptation. Motor-skill learning requires rapid oligodendrocyte production, whereas juvenile social experience regulates prefrontal oligodendrocyte maturation. Visual stimulation evokes astrocytic Ca2+ responses, and voluntary exercise can restore microglial engulfment of excess synapses in a maternal-immune-activation model. Environmental enrichment includes direct and perturbation-based glial evidence, whereas music provides predominantly associative or cell-nonspecific observations. Fragile X studies connect astrocytic dysfunction with motor learning and sensory responses, but the involvement of glia varies with genotype, circuit and developmental stage. The evidence nevertheless differs substantially across systems. Cell-specific causality has been demonstrated for selected astrocytic, microglial and oligodendroglial mechanisms, whereas human intervention studies remain largely cell-nonspecific. Taken together, these findings support glial participation in experience-dependent plasticity but do not establish glial mediation of human interventions. ASD-associated glial states may therefore modify the response to experience, rather than representing targets whose normalization can be assumed to be beneficial.

Neuroglia

22 October 2026

Conceptual framework for experience-dependent neuroglial plasticity. Structured experiences are decomposed into sensory, motor, cognitive, social and systemic signals that can engage astrocytes, microglia and oligodendroglial lineage cells. ASD-associated biology is shown as a modifier of response magnitude, timing and cell state. Solid arrows indicate the proposed sequence from structured experiences to proximal signals, neuroglial responses and circuit consequences. The vertical arrow from ASD-associated cellular variation indicates its potential modulation of neuroglial responses, whereas the dashed arrow represents a parallel glia-independent neuronal pathway from proximal signals to circuit consequences. These arrows represent proposed and testable relationships supported to different degrees and do not imply established glial mediation of human interventions. The illustrated activities are examples rather than the full operational scope of experience-dependent plasticity, which also includes deprivation, altered sensory input and associative learning. Developmental stage, genotype and baseline cellular function condition each proposed relationship.

Featured Articles of Last Quarter

Conceptual evolution of glia-targeted therapeutics from incidental glial modulation to precision glial pharmacology. The framework illustrates the progression from retrospective recognition of glial effects of existing drugs, through mechanism-informed targeting of specific glial pathways, toward context- and patient-informed precision glial pharmacology. Computational approaches increasingly support this evolution by integrating multidimensional biological data, predicting drug–target interactions and therapeutic responses, identifying novel targets and drug-repurposing opportunities, and enabling biomarker-guided patient stratification. These tools therefore act as cross-cutting enablers across the drug-development continuum rather than representing a separate stage of glia-targeted therapeutic development.

Highly Accessed Articles

News & Conferences

Latest Issues

Open for Submission

Journal Sections

XFacebookLinkedIn
Neuroglia - ISSN 2571-6980